Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Ventricular Repolarization by QT Measurement in Transgender People Treated With Hormone Therapy

NCT05865262 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT05865262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05865262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Ventricular Repolarization by QT Measurement in Transgender People Treated With Hormone Therapy
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
November 16, 2021
Completion date
January 1, 2023
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

qtc interval, transgender individuals